Achieve Life Sciences Inc (ACHV)
4.54
-0.01
(-0.22%)
USD |
NASDAQ |
Apr 19, 15:36
Achieve Life Sciences Cash from Operations (TTM): -24.48M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -24.48M |
| September 30, 2023 | -31.26M |
| June 30, 2023 | -37.43M |
| March 31, 2023 | -39.09M |
| December 31, 2022 | -37.57M |
| September 30, 2022 | -31.64M |
| June 30, 2022 | -29.03M |
| March 31, 2022 | -29.77M |
| December 31, 2021 | -29.44M |
| September 30, 2021 | -26.70M |
| June 30, 2021 | -22.34M |
| March 31, 2021 | -15.46M |
| December 31, 2020 | -13.47M |
| September 30, 2020 | -14.41M |
| June 30, 2020 | -13.14M |
| March 31, 2020 | -14.79M |
| December 31, 2019 | -15.22M |
| September 30, 2019 | -15.34M |
| June 30, 2019 | -15.25M |
| March 31, 2019 | -13.28M |
| December 31, 2018 | -10.62M |
| September 30, 2018 | -10.70M |
| June 30, 2018 | -13.18M |
| March 31, 2018 | -11.33M |
| December 31, 2017 | -9.107M |
| Date | Value |
|---|---|
| September 30, 2017 | 17.02M |
| June 30, 2017 | 15.21M |
| March 31, 2017 | 8.874M |
| December 31, 2016 | -0.202M |
| September 30, 2016 | -33.39M |
| June 30, 2016 | -34.76M |
| March 31, 2016 | -11.74M |
| December 31, 2015 | -9.101M |
| September 30, 2015 | -5.36M |
| June 30, 2015 | -2.488M |
| March 31, 2015 | -22.06M |
| December 31, 2014 | -17.31M |
| September 30, 2014 | -17.90M |
| June 30, 2014 | -22.37M |
| March 31, 2014 | -26.93M |
| December 31, 2013 | -35.93M |
| September 30, 2013 | -37.89M |
| June 30, 2013 | -40.59M |
| March 31, 2013 | -46.80M |
| December 31, 2012 | -43.49M |
| September 30, 2012 | -38.44M |
| June 30, 2012 | -31.69M |
| March 31, 2012 | -23.60M |
| December 31, 2011 | -20.26M |
| September 30, 2011 | -19.53M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-39.09M
Minimum
Mar 2023
-13.14M
Maximum
Jun 2020
-23.99M
Average
-24.48M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
| Accelerate Diagnostics Inc | -40.20M |
| ENDRA Life Sciences Inc | -9.549M |
| Perspective Therapeutics Inc | -36.91M |
| Electromed Inc | 4.872M |
| Xtant Medical Holdings Inc | -9.515M |